Stifel Financial Corp Acquires 2,997 Shares of Concentrix Co. (NASDAQ:CNXC)

Stifel Financial Corp raised its position in shares of Concentrix Co. (NASDAQ:CNXCFree Report) by 9.0% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 36,131 shares of the company’s stock after buying an additional 2,997 shares during the period. Stifel Financial Corp owned about 0.06% of Concentrix worth $1,852,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in CNXC. GSA Capital Partners LLP purchased a new stake in shares of Concentrix during the third quarter valued at approximately $1,243,000. Raymond James & Associates raised its position in shares of Concentrix by 73.3% during the 3rd quarter. Raymond James & Associates now owns 55,313 shares of the company’s stock valued at $2,835,000 after buying an additional 23,387 shares in the last quarter. State of Alaska Department of Revenue lifted its holdings in shares of Concentrix by 24.8% in the 3rd quarter. State of Alaska Department of Revenue now owns 64,783 shares of the company’s stock worth $3,319,000 after acquiring an additional 12,870 shares during the last quarter. Intech Investment Management LLC bought a new stake in shares of Concentrix during the third quarter worth $1,255,000. Finally, Sanders Morris Harris LLC purchased a new position in shares of Concentrix during the third quarter valued at $2,562,000. 90.34% of the stock is currently owned by institutional investors.

Concentrix Stock Up 0.2 %

Shares of NASDAQ CNXC opened at $40.48 on Friday. The business has a 50-day moving average of $43.64 and a two-hundred day moving average of $56.96. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.57 and a quick ratio of 1.57. Concentrix Co. has a 1 year low of $36.28 and a 1 year high of $106.10. The company has a market capitalization of $2.62 billion, a price-to-earnings ratio of 13.14, a price-to-earnings-growth ratio of 0.56 and a beta of 0.63.

Concentrix (NASDAQ:CNXCGet Free Report) last issued its earnings results on Wednesday, September 25th. The company reported $2.87 earnings per share for the quarter, missing the consensus estimate of $2.93 by ($0.06). The firm had revenue of $2.39 billion during the quarter, compared to analysts’ expectations of $2.38 billion. Concentrix had a net margin of 2.18% and a return on equity of 16.57%. The firm’s revenue was up 46.2% on a year-over-year basis. During the same period in the previous year, the firm earned $2.54 EPS. On average, analysts forecast that Concentrix Co. will post 10.18 earnings per share for the current fiscal year.

Concentrix Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, November 5th. Shareholders of record on Friday, October 25th were issued a $0.333 dividend. This represents a $1.33 annualized dividend and a dividend yield of 3.29%. The ex-dividend date of this dividend was Friday, October 25th. This is an increase from Concentrix’s previous quarterly dividend of $0.30. Concentrix’s dividend payout ratio is 43.18%.

Insider Buying and Selling

In other news, EVP Cormac J. Twomey sold 1,544 shares of the company’s stock in a transaction on Monday, September 30th. The shares were sold at an average price of $51.38, for a total value of $79,330.72. Following the completion of the transaction, the executive vice president now directly owns 27,783 shares in the company, valued at approximately $1,427,490.54. This represents a 5.26 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Christopher A. Caldwell sold 9,823 shares of the stock in a transaction dated Friday, October 4th. The shares were sold at an average price of $52.70, for a total value of $517,672.10. Following the completion of the transaction, the chief executive officer now directly owns 241,841 shares of the company’s stock, valued at $12,745,020.70. This represents a 3.90 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 12,367 shares of company stock worth $641,668. 3.10% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. Canaccord Genuity Group reduced their price target on Concentrix from $125.00 to $100.00 and set a “buy” rating for the company in a research report on Thursday, September 26th. Baird R W raised shares of Concentrix to a “strong-buy” rating in a report on Thursday, October 3rd. Bank of America reduced their price target on shares of Concentrix from $85.00 to $70.00 and set a “neutral” rating for the company in a research report on Thursday, September 26th. Barrington Research reduced their price objective on Concentrix from $84.00 to $70.00 and set an “outperform” rating for the company in a research note on Thursday, September 26th. Finally, Robert W. Baird initiated coverage on shares of Concentrix in a research note on Thursday, October 3rd. They issued an “outperform” rating and a $70.00 target price for the company. One research analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average price target of $79.00.

Read Our Latest Stock Report on Concentrix

Concentrix Company Profile

(Free Report)

Concentrix Corporation engages in the provision of technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services, across various channels of communication, such as voice, chat, email, social media, asynchronous messaging, and custom applications.

Featured Articles

Institutional Ownership by Quarter for Concentrix (NASDAQ:CNXC)

Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.